Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population

Inclusion Criteria: * Age between 2 to 17 years * Males and females * Clinical diagnosis of mild-to-moderate distal sub-ungual onychomycosis without spikes/dermatophytoma and without lunula involvement or white superficial onychomycosis. * Positive mycroscopy examination from the target nail at screening. * Positive culture for dermatophyte from the target nail at screening. Exclusion Criteria: * Patients with onychomycosis caused by yeasts or non-dermatophytes mould. * Patients with nail psoriasis. * Patients with nail changes due to eczema, lichen planus or alopecia areata. * Patients with one-hand two-foot syndrome. * Patients with immunodeficiency disorder or use of immune suppressive therapy 3 months prior to screening visit or need for it. * Use of systemic antifungal drugs in the 6 months prior to screening visit. * Use of topical nail antifungal drugs in the four weeks prior to screening visit.